Ameritas Investment Partners, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$12,000
+33.3%
6,9130.0%0.00%
Q4 2020$9,000
-10.0%
6,9130.0%0.00%
Q3 2020$10,000
+25.0%
6,9130.0%0.00%
Q2 2020$8,0000.0%6,9130.0%0.00%
Q1 2020$8,000
-46.7%
6,9130.0%0.00%
-100.0%
Q4 2019$15,0000.0%6,9130.0%0.00%0.0%
Q3 2019$15,000
-11.8%
6,9130.0%0.00%0.0%
Q2 2019$17,000
+88.9%
6,913
+150.7%
0.00%
Q1 2017$9,0002,7580.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Perceptive Advisors 5,995,760$16,129,0001.12%
Palo Alto Investors LP 1,425,439$3,834,0000.29%
Granahan Investment Management 1,438,736$3,870,0000.14%
WealthTrust Axiom LLC 130,000$349,0000.13%
SHEPHERD KAPLAN KROCHUK, LLC 127,846$344,0000.09%
NIPPON LIFE INSURANCE CO 17,192$2,247,0000.06%
Joel Isaacson & Co., LLC 80,660$217,0000.05%
Cornerstone Capital, Inc. 47,200$127,0000.03%
OXFORD ASSET MANAGEMENT LLP 153,769$414,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 281,650$758,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders